Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival

 Abstract

Clinical outcomes in breast cancer are likely influenced by modifier genes that affect tumor dormancy versus progression. The Bin1 gene encodes a nucleocytosolic adapter protein that suppresses neoplastic cell transformation and that is often attenuated in human breast carcinoma. Recent mouse genetic studies indicate that Bin1 loss cooperates with ras activation to drive progression of mammary carcinoma, establishing Bin1 as a negative modifier of tumor progression in breast cancer. In this study, we investigated whether immunohistochemical losses of nuclear Bin1 proteins in cases of human breast cancer were correlated to progression status. In American and Japanese groups of low or middle grade breast cancers, losses were associated with reduced survival and increased nodal metastasis, respectively. Taken together with recent findings from mouse genetic studies, these findings encourage further evaluation of the potential utility of Bin1 as a clinical prognostic marker in breast cancer.

Full Text Options
Article
Metrics
 Share
 Info
Pages
192 - 194
doi
10.4161/cbt.6.2.3587
Type
Research Paper
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Bin1 attenuation in breast cancer is correlated to nodal metastasis and reduced survival